acetazolamide has been researched along with Disease Exacerbation in 15 studies
Acetazolamide: One of the CARBONIC ANHYDRASE INHIBITORS that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate whether acetazolamide, already found to be helpful in decreasing cystoid macular edema in patients with retinitis pigmentosa, was also effective in the treatment of diabetic macular edema in nonproliferative retinopathy." | 9.09 | Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study. ( Forte, R; Gargiulo, P; Giusti, C; Vingolo, EM, 2001) |
| "Vascular calcification is a recognised source of morbidity among mid-age and elderly subjects." | 5.51 | Would acetazolamide inhibit progression of atheromatous vascular calcification? ( Cochran, M, 2019) |
| "To investigate whether acetazolamide, already found to be helpful in decreasing cystoid macular edema in patients with retinitis pigmentosa, was also effective in the treatment of diabetic macular edema in nonproliferative retinopathy." | 5.09 | Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study. ( Forte, R; Gargiulo, P; Giusti, C; Vingolo, EM, 2001) |
| " The present study was aimed at testing the hypothesis that regional cerebrovascular reactivity (rCVR) to acetazolamide can be a reliable predictor of subsequent ischemic stroke in medically treated patients with internal carotid artery or middle cerebral artery occlusion." | 5.09 | Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it? ( Abe, H; Houkin, K; Iwasaki, Y; Kamiyama, H; Kuroda, S; Mitsumori, K, 2001) |
| "Meniere's disease is a clinical syndrome of uncertain aetiology but it is a widespread belief that it is related to endolymphatic hydrops." | 2.43 | Hypothesis: could Meniere's disease be a channelopathy? ( Gates, P, 2005) |
| "Vascular calcification is a recognised source of morbidity among mid-age and elderly subjects." | 1.51 | Would acetazolamide inhibit progression of atheromatous vascular calcification? ( Cochran, M, 2019) |
| "Acetazolamide treatment is effective in most cases, and it represents a viable alternative to repeated LP." | 1.51 | Pseudotumour cerebri in children: Aetiology, clinical features, and progression. ( Aguilera Albesa, S; Azcona Ganuza, G; Gembero Esarte, E; Iridoy Zulet, M; Mosquera Gorostidi, A; Yoldi Petri, ME, 2019) |
| "For a diagnosis of idiopathic intracranial hypertension (IIH), she was treated with acetazolamide and methylprednisolone, but vision worsened, so she underwent bilateral optic sheath fenestration (ONSF)." | 1.35 | Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration. ( Siatkowski, RM; Wilkes, BN, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.67) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 4 (26.67) | 24.3611 |
| 2020's | 2 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cochran, M | 1 |
| Callen, AL | 1 |
| Dupont, SM | 1 |
| Pyne, J | 1 |
| Talbott, J | 1 |
| Tien, P | 1 |
| Calabrese, E | 1 |
| Saloner, D | 1 |
| Chow, FC | 1 |
| Narvid, J | 1 |
| Pramila, PJ | 1 |
| Mannam, P | 1 |
| Chacko, AG | 1 |
| Benjamin, RN | 1 |
| Albrecht, P | 1 |
| Blasberg, C | 1 |
| Ringelstein, M | 1 |
| Müller, AK | 1 |
| Finis, D | 1 |
| Guthoff, R | 1 |
| Kadas, EM | 1 |
| Lagreze, W | 1 |
| Aktas, O | 1 |
| Hartung, HP | 1 |
| Paul, F | 1 |
| Brandt, AU | 1 |
| Methner, A | 1 |
| Kim, SJ | 1 |
| Son, TO | 1 |
| Kim, KH | 1 |
| Jeon, P | 1 |
| Hyun, SH | 1 |
| Lee, KH | 1 |
| Yeon, JY | 1 |
| Kim, JS | 2 |
| Hong, SC | 1 |
| Shin, HJ | 1 |
| Bang, OY | 1 |
| Mosquera Gorostidi, A | 1 |
| Iridoy Zulet, M | 1 |
| Azcona Ganuza, G | 1 |
| Gembero Esarte, E | 1 |
| Yoldi Petri, ME | 1 |
| Aguilera Albesa, S | 1 |
| Wilkes, BN | 1 |
| Siatkowski, RM | 1 |
| Giusti, C | 1 |
| Forte, R | 1 |
| Vingolo, EM | 1 |
| Gargiulo, P | 1 |
| Lane, M | 1 |
| McBride, J | 1 |
| Archer, J | 1 |
| Gates, P | 1 |
| Cricchi, F | 1 |
| Di Lorenzo, C | 1 |
| Grieco, GS | 1 |
| Rengo, C | 1 |
| Cardinale, A | 1 |
| Racaniello, M | 1 |
| Santorelli, FM | 1 |
| Nappi, G | 1 |
| Pierelli, F | 1 |
| Casali, C | 1 |
| Kim, JM | 1 |
| Ryu, WS | 1 |
| Hwang, YH | 1 |
| Golnik, KC | 1 |
| Devoto, TM | 1 |
| Kersten, RC | 1 |
| Kulwin, D | 1 |
| Yabe, I | 1 |
| Sasaki, H | 1 |
| Yamashita, I | 1 |
| Takei, A | 1 |
| Tashiro, K | 1 |
| Kuroda, S | 1 |
| Houkin, K | 1 |
| Kamiyama, H | 1 |
| Mitsumori, K | 1 |
| Iwasaki, Y | 1 |
| Abe, H | 1 |
1 review available for acetazolamide and Disease Exacerbation
| Article | Year |
|---|---|
Hypothesis: could Meniere's disease be a channelopathy?
Topics: Acetazolamide; Adult; Aged; Disease Progression; Endolymphatic Hydrops; Female; Genetic Predispositi | 2005 |
3 trials available for acetazolamide and Disease Exacerbation
| Article | Year |
|---|---|
Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study.
Topics: Acetazolamide; Carbonic Anhydrase Inhibitors; Comorbidity; Diabetes Mellitus, Type 1; Diabetes Melli | 2001 |
Clinical trial of acetazolamide in SCA6, with assessment using the Ataxia Rating Scale and body stabilometry.
Topics: Acetazolamide; Adult; Aged; Anticonvulsants; Disease Progression; Female; Humans; Male; Middle Aged; | 2001 |
Long-term prognosis of medically treated patients with internal carotid or middle cerebral artery occlusion: can acetazolamide test predict it?
Topics: Acetazolamide; Aged; Blood Flow Velocity; Brain; Carbonic Anhydrase Inhibitors; Carotid Stenosis; Ce | 2001 |
11 other studies available for acetazolamide and Disease Exacerbation
| Article | Year |
|---|---|
Would acetazolamide inhibit progression of atheromatous vascular calcification?
Topics: Acetazolamide; Acidosis; Aged; Alkaline Phosphatase; Calcium; Disease Progression; Humans; Hydrogen- | 2019 |
The regional pattern of abnormal cerebrovascular reactivity in HIV-infected, virally suppressed women.
Topics: Acetazolamide; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Basal Ganglia; Cerebral Arter | 2020 |
Progressive midbrain clefts after head trauma and decompressive surgery: a report of two patients.
Topics: Acetazolamide; Ataxia; Blepharoptosis; Brain Diseases; Brain Injuries, Diffuse; Carbonic Anhydrase I | 2021 |
Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.
Topics: Acetazolamide; Adult; Algorithms; Atrophy; Carbonic Anhydrase Inhibitors; Case-Control Studies; Dise | 2017 |
Neovascularization precedes occlusion in moyamoya disease: angiographic findings in 172 pediatric patients.
Topics: Acetazolamide; Brain; Cardiovascular Agents; Cerebral Angiography; Cerebrovascular Circulation; Chil | 2014 |
Pseudotumour cerebri in children: Aetiology, clinical features, and progression.
Topics: Acetazolamide; Adolescent; Child; Disease Progression; Female; Humans; Male; Pseudotumor Cerebri; Re | 2019 |
Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration.
Topics: Acetazolamide; Adolescent; Decompression, Surgical; Disease Progression; Female; Humans; Methylpredn | 2009 |
Steroid responsive late deterioration in Cryptococcus neoformans variety gattii meningitis.
Topics: Acetazolamide; Adult; Amphotericin B; Antifungal Agents; Arachnoiditis; Cerebral Infarction; Dexamet | 2004 |
Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop.
Topics: Acetazolamide; Age of Onset; Amino Acid Substitution; Calcium Channels; Carbonic Anhydrase Inhibitor | 2007 |
Aggravation of ataxia due to acetazolamide induced hyperammonaemia in episodic ataxia.
Topics: Acetazolamide; Acidosis; Ammonia; Ataxia; Carbonic Anhydrase Inhibitors; Disease Progression; Humans | 2007 |
Visual loss in idiopathic intracranial hypertension after resolution of papilledema.
Topics: Acetazolamide; Administration, Oral; Adult; Blindness; Disease Progression; Diuretics; Female; Human | 1999 |